U.S. Markets closed

Cepheid (CPHD) Looks Good: Stock Adds 5.3% in Session

Zacks Equity Research

Cepheid (CPHD) was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company, as the stock is now down nearly 6% since Apr 1, 2014.

The company has seen no estimate revision over the past 30 days, while the Zacks Consensus Estimate remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cepheid currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked medical stocks include Cynosure, Inc. (CYNO), Delcath Systems, Inc. (DCTH) and Syneron Medical Ltd. (ELOS). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

CEPHEID INC (CPHD): Free Stock Analysis Report

CYNOSURE INC (CYNO): Free Stock Analysis Report

SYNERON MEDICAL LTD ORD (ELOS): Free Stock Analysis Report

DELCATH SYSTEMS INC (DCTH): Free Stock Analysis Report

Zacks Investment Research